Current Assets

Short- term Investments

Year-over-year, this metric declined by 37.4%, from $599.00M to $375.00M.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2014
Last reportedQ1 2026May 4, 2026
Metric ID: current_assets_marketable_securities_current

Historical Data

12 periods
 Q4 '22Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$498.00M$168.00M$252.00M$40.00M$50.00M$0.00$447.00M$599.00M$615.00M$45.00M$0.00$375.00M
QoQ Change-66.3%+50.0%-84.1%+25.0%-100.0%+34.0%+2.7%-92.7%-100.0%
YoY Change-49.4%-100.0%+77.4%>999%>999%-100.0%-37.4%
Range$0.00$615.00M
CAGR-9.8%
Avg YoY Growth+331.2%
Median YoY Growth-37.4%
Current Streak3 quarters decline

Frequently Asked Questions

What is Merck & Co.'s short- term investments?
Merck & Co. (MRK) reported short- term investments of $375.00M in Q1 2026.
How has Merck & Co.'s short- term investments changed year-over-year?
Merck & Co.'s short- term investments decreased by 37.4% year-over-year, from $599.00M to $375.00M.